Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Chamorey

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Surgical Oncology|August 29, 2020
Oral and oropharyngeal cancer surgery with free-flap reconstruction in the elderly: Factors associated with long-term quality of life, patient needs and concerns. A GETTEC cross-sectional studyAlexandre Bozec, Claire Majoufre, Marie De Boutray, et al.
BMJ Open|February 24, 2019
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)David Pérol, Mathieu Robain, Patrick Arveux, et al.
British Journal of Cancer|August 30, 2017
CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomasMaeva Dufies, Sandy Giuliano, Julien Viotti, et al.
Oral Oncology|March 18, 2014
Cervical node of unknown primary: patterns of care and factors influencing the choice of clinical target volumesIdriss Troussier, René-Jean Bensadoun, Emmanuel Chamorey, et al.
Communications Biology|February 6, 2021
Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinomaMaeva Dufies, Annelies Verbiest, Lindsay S Cooley, et al.
Theranostics|March 21, 2020
Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patientsLucilla Fabbri, Maeva Dufies, Sandra Lacas-Gervais, et al.
Oral Oncology|October 31, 2020
Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2020
Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric studyDorian Culié, Julien Viotti, Anouchka Modesto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 4, 2021
Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric studyDorian Culié, Renaud Schiappa, Anouchka Modesto, et al.
Oral Oncology|September 9, 2021
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Surgical Oncology|August 29, 2020
Oral and oropharyngeal cancer surgery with free-flap reconstruction in the elderly: Factors associated with long-term quality of life, patient needs and concerns. A GETTEC cross-sectional studyAlexandre Bozec, Claire Majoufre, Marie De Boutray, et al.
BMJ Open|February 24, 2019
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)David Pérol, Mathieu Robain, Patrick Arveux, et al.
British Journal of Cancer|August 30, 2017
CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomasMaeva Dufies, Sandy Giuliano, Julien Viotti, et al.
Oral Oncology|March 18, 2014
Cervical node of unknown primary: patterns of care and factors influencing the choice of clinical target volumesIdriss Troussier, René-Jean Bensadoun, Emmanuel Chamorey, et al.
Communications Biology|February 6, 2021
Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinomaMaeva Dufies, Annelies Verbiest, Lindsay S Cooley, et al.
Theranostics|March 21, 2020
Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patientsLucilla Fabbri, Maeva Dufies, Sandra Lacas-Gervais, et al.
Oral Oncology|October 31, 2020
Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2020
Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric studyDorian Culié, Julien Viotti, Anouchka Modesto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 4, 2021
Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric studyDorian Culié, Renaud Schiappa, Anouchka Modesto, et al.
Oral Oncology|September 9, 2021
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
Pageof 16